These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

671 related items for PubMed ID: 16795071

  • 1. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL, Shyu RY, Hsieh CB, Lai HC, Liu KY, Chu TY, Lin YW.
    Cancer; 2006 Aug 01; 107(3):579-90. PubMed ID: 16795071
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.
    Huang J, Zhang YL, Teng XM, Lin Y, Zheng DL, Yang PY, Han ZG.
    BMC Cancer; 2007 Jul 12; 7():126. PubMed ID: 17626620
    [Abstract] [Full Text] [Related]

  • 3. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
    Wu Y, Li J, Sun CY, Zhou Y, Zhao YF, Zhang SJ.
    Neoplasma; 2012 Jul 12; 59(3):326-32. PubMed ID: 22296502
    [Abstract] [Full Text] [Related]

  • 4. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E, Wiesmann F, Woenckhaus M, Stoehr R, Wild PJ, Veeck J, Knüchel R, Klopocki E, Sauter G, Simon R, Wieland WF, Walter B, Denzinger S, Hartmann A, Hammerschmied CG.
    Oncogene; 2007 Aug 16; 26(38):5680-91. PubMed ID: 17353908
    [Abstract] [Full Text] [Related]

  • 5. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
    Awakura Y, Nakamura E, Ito N, Kamoto T, Ogawa O.
    Oncol Rep; 2008 Nov 16; 20(5):1257-63. PubMed ID: 18949430
    [Abstract] [Full Text] [Related]

  • 6. Frequent concomitant epigenetic silencing of SOX1 and secreted frizzled-related proteins (SFRPs) in human hepatocellular carcinoma.
    Shih YL, Hsieh CB, Yan MD, Tsao CM, Hsieh TY, Liu CH, Lin YW.
    J Gastroenterol Hepatol; 2013 Mar 16; 28(3):551-9. PubMed ID: 23215838
    [Abstract] [Full Text] [Related]

  • 7. HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing.
    Yau TO, Chan CY, Chan KL, Lee MF, Wong CM, Fan ST, Ng IO.
    Oncogene; 2005 Feb 24; 24(9):1607-14. PubMed ID: 15580286
    [Abstract] [Full Text] [Related]

  • 8. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D.
    Laryngoscope; 2005 Aug 24; 115(8):1395-401. PubMed ID: 16094112
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.
    Ann Surg Oncol; 2010 Mar 24; 17(3):923-32. PubMed ID: 19898900
    [Abstract] [Full Text] [Related]

  • 10. [Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer].
    Dahl E, Veeck J, An H, Wiesmann F, Klopocki E, Sauter G, Kristiansen G, Hartmann A, Knüchel R.
    Verh Dtsch Ges Pathol; 2005 Mar 24; 89():169-77. PubMed ID: 18035687
    [Abstract] [Full Text] [Related]

  • 11. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G.
    Gastroenterology; 2008 Dec 24; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [Abstract] [Full Text] [Related]

  • 12. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E.
    Breast Cancer Res; 2008 Dec 24; 10(5):R82. PubMed ID: 18826564
    [Abstract] [Full Text] [Related]

  • 13. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
    Mori T, Nomoto S, Koshikawa K, Fujii T, Sakai M, Nishikawa Y, Inoue S, Takeda S, Kaneko T, Nakao A.
    Liver Int; 2005 Apr 24; 25(2):380-8. PubMed ID: 15780064
    [Abstract] [Full Text] [Related]

  • 14. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
    Shutoh M, Oue N, Aung PP, Noguchi T, Kuraoka K, Nakayama H, Kawahara K, Yasui W.
    Cancer; 2005 Oct 15; 104(8):1609-19. PubMed ID: 16134180
    [Abstract] [Full Text] [Related]

  • 15. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, Zheng SS.
    Ann Surg Oncol; 2008 Dec 15; 15(12):3494-502. PubMed ID: 18830757
    [Abstract] [Full Text] [Related]

  • 16. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
    Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K.
    Oncogene; 2000 Nov 02; 19(46):5298-302. PubMed ID: 11077447
    [Abstract] [Full Text] [Related]

  • 17. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA.
    Hepatology; 2002 Sep 02; 36(3):692-701. PubMed ID: 12198663
    [Abstract] [Full Text] [Related]

  • 18. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
    Lv Z, Zhang M, Bi J, Xu F, Hu S, Wen J.
    Am J Clin Pathol; 2006 May 02; 125(5):740-6. PubMed ID: 16707376
    [Abstract] [Full Text] [Related]

  • 19. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway.
    Shih YL, Hsieh CB, Lai HC, Yan MD, Hsieh TY, Chao YC, Lin YW.
    Int J Cancer; 2007 Sep 01; 121(5):1028-35. PubMed ID: 17443492
    [Abstract] [Full Text] [Related]

  • 20. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E.
    Mol Cancer; 2008 Nov 06; 7():83. PubMed ID: 18990230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.